Research library / Omega-3

CC Small or few human trials. Promising, not proven. How we grade →Biomarker substudy of an RCT · REDUCE-IT participants

Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy

P Ridker, N Rifai, J MacFadyen, R Glynn, L Jiao, P Steg et al. Circulation. 2022.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
Atherosclerosis-linked markers rose in REDUCE-IT's mineral oil group (for example, hs-CRP up 21.9% at 12 months) and barely changed with icosapent ethyl; impact on the event results is uncertain.
Limits
Biomarkers, not events; cannot settle how much the placebo shaped REDUCE-IT's result.
Which of our grades it feeds
Source
doi.org/10.1161/CIRCULATIONAHA.122.059410 · PubMed 35762321

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.